Navigation Links
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
Date:5/15/2008

KV is Now Offering The Complete Line of All Four Dosage Strengths of Generic Metoprolol Succinate Extended-Release Tablets Following Approval of

the 50 mg Tablet

ST. LOUIS, May 15 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology-differentiated branded products and generic/non-branded prescription pharmaceuticals, announced today that it has received final approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) to market its 50 mg strength of metoprolol succinate extended-release tablets. The Company expects to begin shipping immediately. This product is a generic version of AstraZeneca's branded product, Toprol-XL(R) and the 50 mg strength recorded total branded and generic dollar volume in 2007 of $585 million according to IMS America. The 50 mg strength is the largest of the four strengths in both units sold and dollar volume.

As a result of the 50 mg approval, KV is now offering the complete line of all four dosage strengths of metoprolol succinate extended-release tablets -- 200 mg, 100 mg, 50 mg and 25 mg. KV currently has a 77.8% and 77.4% market share for the 200 mg and 100 mg strengths, respectively. Based on the Company's first-to-file status on its ANDA for these two strengths, KV was accorded the benefit of a 180-day generic exclusivity period for the marketing of these two dosage strengths. Even though KV was not granted an exclusivity period for the 50 mg or 25 mg dosage strengths, the Company currently has a 23.5% market share for the 25 mg strength which was only approved by the FDA on March 20, 2008.

Marc S. Hermelin, Vice Chairman and Chief Executive Officer of KV Pharmaceutical stated, "Following today's approval, KV is now able to offer all four dosage strengths of metoprolol succinate extended-release tablets
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Transdel Pharmaceuticals Closes $4 Million Financing
2. Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities
3. XTL Biopharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
4. Illinois Pharmaceutical Manufacturer Sued for Injuries to Kentucky Resident
5. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
6. Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
7. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Memory Pharmaceuticals Reports First Quarter 2008 Financial Results
9. Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
10. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
11. Medimetriks Pharmaceuticals, Inc. Begins Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...FORD, Mass., Nov. 19 Serica Techno...ny developing silk-based biomaterial,platforms fo... received ISO,13485:2003 certification, meeting s... for medical device manufacturers. ISO certificati...t regulatory bodies worldwide as proof of an,effe...
(Date:11/19/2008)... - Marine omega-3 phospholipids in NKO(R) out...pharmaceutical omega-3 formulations -, - ...ription drug, pr...e-FirstCall/ - Neptune Technologies & Bioresso...s pleased to announce positive results from a huma...
(Date:11/19/2008)... Trusted LASIK Surgeons laun...ectory service and website at www.TrustedLASIKSur...umers seeking to improve their vision. What sets t...que screening process ensuring that only those who...rgeons in the United States are listed. Refractive...
(Date:11/19/2008)...pany prepares to launch Moxatag(TM), the first and...first quarter of 2009 , , GERMANTOWN, Md., ...maceuticals, Inc. (Nasdaq: MBRK ), today announc...members: , , , , Frank L. Koos ...ice president, sales & business development. ...
Breaking Biology Technology:Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing 2Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing 3Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing 4Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile 2Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile 3Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile 4Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory 2Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory 3Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory 4Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory 5Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory 6MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 2MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 3MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 4MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 5
...rformance of New MessageAmp II on High Density Oli... New ArrayScript, an M-MLV RT ,...of full-length cDNA , Amplif...t RNA in a single round for GeneChip , ...thesis powered by , MEGAscript,...
...poration of Primary, Neuronal and Other Hard-to-tr...enko, Rich Jarvis, , Kevin Keln... , RNA interference (RNAi) i...l for reducing the expression of specific , ...function analysis, target , val...
... Ambion,s newest line of plasmid siRNA ...cer 4.1-CMV, , feature polym..., of both an siRNA template and... The CMV promoter is used to drive siRNA express...active in a broad range of cell types and , ...
... Trace amounts of ribonuclease (RNase) ...periments. Since RNases are , u...kin, in the , air, on anything ... open to the air--it is important to m...liminate RNase contamination. However, determining...
Other Biology Technology:Improving RNA Amplification 2Improving RNA Amplification 3Improving RNA Amplification 4Improving RNA Amplification 5Improving RNA Amplification 6Improving RNA Amplification 7Improving RNA Amplification 8Improving RNA Amplification 9Improving RNA Amplification 10Improving RNA Amplification 11Improving RNA Amplification 12Improving RNA Amplification 13Improving RNA Amplification 14Delivering siRNAs to Difficult Cell Types 2Delivering siRNAs to Difficult Cell Types 3Delivering siRNAs to Difficult Cell Types 4Delivering siRNAs to Difficult Cell Types 5Delivering siRNAs to Difficult Cell Types 6Delivering siRNAs to Difficult Cell Types 7Drive Long-Term Silencing with CMV Vectors 2Drive Long-Term Silencing with CMV Vectors 3Combat RNase Contamination in the Lab 2Combat RNase Contamination in the Lab 3Combat RNase Contamination in the Lab 4Combat RNase Contamination in the Lab 5
(Date:11/19/2008)...hemical Society (ACS) News Service Weekly PressPac... Chemical & Engineering News .,Please credit the...ty as the source for this information. , ALL CON...hich is embargoed for 9 a. m., Eastern Time, Novem...RELEASE , Microcapsules act as "roach motel" to...
(Date:11/19/2008)...tra treats this holiday season? Soon, your cell ph... routine and keep the pounds off over winter month...ack. , Researchers at the University of Washingt...cations, dubbed UbiFit and UbiGreen, to automatica...rograms display motivational pictures on the phone...
(Date:11/19/2008)...rchers at Carnegie Mellon University,s Robotics In...ants from the U.S. Department of Agriculture (USDA...pple growers and one is for orange growers, but bo... production costs. , The systems use sensors on ...in the orchards to gather a multitude of data abou...
(Date:11/19/2008)...y a University of Central Florida professor show e..., Associate Professor James Turkson,s compounds ...tumors in tests on mice. The compounds, S3I-201 a...lled STAT3, and researchers have observed no negat...ry promising," Turkson said. "They,ve worked very ...
Breaking Biology News(10 mins):American Chemical Society's Weekly PressPac -- Nov. 19, 2008 2American Chemical Society's Weekly PressPac -- Nov. 19, 2008 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 4American Chemical Society's Weekly PressPac -- Nov. 19, 2008 5American Chemical Society's Weekly PressPac -- Nov. 19, 2008 6American Chemical Society's Weekly PressPac -- Nov. 19, 2008 7American Chemical Society's Weekly PressPac -- Nov. 19, 2008 8Track your fitness, environmental impact with new cell phone applications 2Track your fitness, environmental impact with new cell phone applications 3Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 2Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 32 new compounds show promise for eliminating breast cancer tumors 2Allergy Disorders Linked With Irritable Bowel Syndrome 12095 1Allergy Disorders Linked With Irritable Bowel Syndrome 12095 2New findings on emerging contaminants 12092 1New findings on emerging contaminants 12092 2New findings on emerging contaminants 12092 3New findings on emerging contaminants 12092 4New findings on emerging contaminants 12092 5An Open Letter to 20 20 and the Shareholders of Premier Exhibitions Inc 12088 1An Open Letter to 20 20 and the Shareholders of Premier Exhibitions Inc 12088 2An Open Letter to 20 20 and the Shareholders of Premier Exhibitions Inc 12088 3From stem cells to organs 3A The bioengineering challenge 2231 1From stem cells to organs 3A The bioengineering challenge 2231 2
...ientists at The University of Texas at Austin prot...t the use of antibiotics and other more expensive ...ax antitoxin, successfully eliminated both anthrax...f future tests concur, this could be the first suc..., even for an anthrax strain that has been designe...
...ve an increased risk of schizophrenia, consistent ...etal nutritional deficiency and schizophrenia, acc... theme issue on violence and human rights. , Schiz... characterized by thought disorder, hallucinations...ial functioning and social withdrawal, according t...
... with cheap processing fluidsIn an important advan...nt quantum dots, scientists at Rice University hav...olvents used in quantum dot synthesis with cheaper...plants. , Rice,s study, which was conducted under ...ronmental Nanotechnology (CBEN), is published onli...
... University of California, San Diego that appears ...r found that females of the species Uca crenulata ...heir burrows before finally deciding on a mate. , ...ved sampling nearly as many candidates as the Cali...conducted the study while a doctoral student and a...
Other Biology News:New antibody shows promise as cure for anthrax 2New antibody shows promise as cure for anthrax 3Prenatal exposure to famine increases risk of schizophrenia 2The right drug at the right time 2The right drug at the right time 3Biologist Discovers What May Be World’s ‘Pickiest?Mates 2Biologist Discovers What May Be World’s ‘Pickiest?Mates 3
Vitellogenin (Japanese medaka) Standard
Mouse Collagen IV
The Captivate Disposable Sample Chamber is designed for use with the Captivate magnetic yoke assembly (C-24700) and can be used with our Captivate ferrofluid conjugates (C-21473 C-21474 C-21476) or
Sheep Serum US Origin
Biology Products: